RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial
Hamadani, M., Spira, A. I., Zhou, X., Liao, L., Chen, L., Radford, J., Ai, W. Z., Solh, M. M., Ardeshna, K. M., Hess, B. T., Caimi, P. F., Stathis, A., Carlo Stella, C., Alderuccio, J. P., Kahl, B. S., Wang, Y., Qin, Y. G., Xu, Z. C., & Zinzani, P. L. (2024). Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial. Blood advances, 8(1), 93-98. https://doi.org/10.1182/bloodadvances.2023010636